$AVBP
ArriVent BioPharma, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Newtown Square, PA
AVBP chart
What traders are saying about $AVBP
Latest postsArriVent BioPharma, Inc. news
- Precision Trading with Arrivent Biopharma Inc. (AVBP) Risk Zones
Stock Traders Daily ·
- Analysts’ Top Healthcare Picks: Crispr Therapeutics AG (CRSP), Faeth Therapeutics (FTH)
The Globe and Mail ·
- ArriVent BioPharma (AVBP) Institutional Ownership 2026
MarketBeat ·
- Aarvik Therapeutics Announces Milestone Achievement, Partnership Update, and Presentations on MUTTA™ and AQUALINK™ Platforms at the 17th Annual WADC Conference
Yahoo Finance ·
- A cancer drug has reached its first patient in a U.S. trial. It’s the first from Aarvik’s platform to enter testing.
Stock Titan ·
- ArriVent BioPharma’s ARR-217 Shows 44.8% Response Rate in Colorectal Cancer Study
marketbeat.com ·
- ArriVent BioPharma (AVBP) Advances ARR 217 Into Phase 1b, Is The Selloff Overdone?
Yahoo Finance ·
- ArriVent Announces Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at ESMO Congress 2026
Yahoo Finance ·
- Why ArriVent BioPharma Stock Is In Focus After Trial Failure And Legal Probe
Yahoo Finance ·
- ArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026
Yahoo Finance ·
- ArriVent Announces Cancer Cell Publication Highlighting Firmonertinib in EGFR PACC-Mutant Non-Small Cell Lung Cancer
Yahoo Finance ·
- ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002
Yahoo Finance ·
ArriVent BioPharma, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$166.3M | -$80.5M | -$69.3M |
| Diluted EPS | $-4.32 | $-2.56 | $-32.38 |
| Total assets (year end) | $333.2M | $274.9M | $163.1M |
| Cash and equivalents (year end) | $45.5M | $74.3M | $150.4M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About ArriVent BioPharma, Inc.
- Ticker
- AVBP (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Newtown Square, PA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1868279
Frequently asked questions
What exchange is ArriVent BioPharma, Inc. listed on?
ArriVent BioPharma, Inc. trades on the Nasdaq under the ticker symbol AVBP.
What industry is ArriVent BioPharma, Inc. in?
ArriVent BioPharma, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is ArriVent BioPharma, Inc. headquartered?
ArriVent BioPharma, Inc.'s business address on file with the SEC is in Newtown Square, PA.
When does ArriVent BioPharma, Inc.'s fiscal year end?
ArriVent BioPharma, Inc.'s fiscal year ends on December 31.